Published: 3 May 2019
Author(s): Thomas Datzmann, Susanne Fuchs, Daniel Andree, Bernd Hohenstein, Jochen Schmitt, Christoph Schindler
Issue: May 2019
Section: Review Article

The potential influence of angiotensin-receptor blockers (ARBs) on carcinogenesis is a much-debated topic. Both observational, as well as preclinical studies in rodent carcinogenic assays, suggest a major role of the Renin-Angiotensin-Aldosterone-System (RAAS) in cancer development. Therefore, a systematic review and meta-analysis with available study data on ARBs and carcinogenicity in general as primary outcome were conducted. Secondary outcomes were defined as tumour-specific mortality rates and the frequency of new cases of specific tumour types with particular emphasis on lung, breast, and prostate cancer.


Stay informed on our latest news!